Caplin Point Labs schedules AGM with ₹8 per share dividend payout
- Caplin Point Laboratories schedules 35th AGM for September 25, 2026
- Total FY26 dividend payout stands at ₹8 per share
- Board seeks approval for re-appointment of MD and appointment of WTD
- E-voting opens on September 22, 2026, and closes on September 24, 2026

*this image is generated using AI for illustrative purposes only.
Caplin Point Laboratories has scheduled its 35th Annual General Meeting for September 25, 2026. The meeting will be held via Video Conferencing or Other Audio-Visual Means at 10:00 am.
The Board has recommended a final dividend of ₹4 per equity share of face value ₹2 each. This adds to the interim dividend of ₹4 already declared, bringing the total dividend for FY26 to ₹8 per share (400%). Shareholders on record as of September 18, 2026 will be eligible for the final payout.
Key Agenda Items
The meeting agenda focuses on adopting financial statements and approving significant board-level appointments and continuations.
Board Appointments and Continuations
Three special resolutions require shareholder approval regarding the company's leadership structure:
- Re-appointment of Managing Director: Dr. Sridhar Ganesan (DIN: 06819026) seeks re-appointment as Managing Director for two years, from August 25, 2026, to August 24, 2028. His annual salary is set at ₹55,20,000, with additional perquisites subject to Schedule V limits.
- Continuation of Chairman: Mr. C. C. Paarthipan (DIN: 01218784) seeks approval to continue as Chairman and Non-Executive, Non-Independent Director despite attaining the age of 75 during his tenure. He receives no remuneration.
- Appointment of Whole-Time Director: Mr. D. Muralidharan (DIN: 08301904), currently the Chief Financial Officer, is appointed as Whole-Time Director for two years starting August 12, 2026. His annual salary is fixed at ₹62,37,600. He will continue to serve as CFO without additional compensation.
E-Voting Details
Remote e-voting opens on September 22, 2026, at 9:00 am and closes on September 24, 2026, at 5:00 pm. The cut-off date for determining voting eligibility is September 18, 2026. Members can vote via the National Securities Depository Limited platform.
Historical Stock Returns for Caplin Point Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.85% | -0.46% | +9.01% | +76.08% | +34.71% | +210.30% |
How might the re-appointment of Dr. Sridhar Ganesan and the promotion of the CFO to Whole-Time Director influence Caplin Point's strategic growth plans for FY27-28?
What are the potential market reactions to the 400% total dividend payout, and does this signal strong cash flow generation or a lack of high-return reinvestment opportunities?
Given Mr. C. C. Paarthipan's continuation as Chairman despite exceeding the age limit, what governance risks or stability benefits does this structure present to investors?


































